This co-development partnership aims to develop an innovative minimally invasive medical device for the treatment of acute cartilage lesions.

HeartGenetics and Agena Bioscience signed a commercial partnership to bring affordable genetic testing to the market.

HeartGenetics is an innovative Portuguese biotech and bioinformatics company revolutionizing genetic testing.

During the investment period, Nonius grew from a turnover of EUR 50k to EUR 7 million.

Operating in Brazil since 2011, with a branch in São Paulo, Nonius reaches a milestone of 300 customers in Latin America.